Skip to main content
Log in

Sucrose Octaacetate Chemical Kinetics and Shelf Lives at Various Formulation pHs

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Developing pediatric friendly dosage forms is a high priority worldwide. Sucrose octaacetate (SOA) has been recommended for use as a surrogate for bitter tasting active pharmaceutical ingredients. Even though SOA has found a number of human use applications and has been employed for decades, there are no rigorous chemical kinetic studies reported. A recently reported SOA stability-indicating method was used to perform SOA chemical kinetic and stability studies. As part of the chemical kinetic study, reaction order, activation energies, extrapolated rate constants, pH–rate profiles at 4 and 25°C, and estimated shelf lives at 4 and 25°C at different buffer pHs are provided. The estimated SOA shelf lives at 25°C and pHs 4.00, 5.20, and 6.00 were 25.3, 114, and 27.4 days, respectively. At 4°C, SOA’s estimated shelf lives were 0.478, 5.26, and 1.47 years at pHs 4.00, 5.20, and 6.00, respectively. SOA can be formulated at pHs 4 to 6 and stored at 25°C for short-duration (less than 25 days) uses such as a bitter tasting surrogate for fundamental taste mechanism studies or brief taste masking assessment clinical studies. For longer term solution studies, like being used as a bitter tasting control for blinded clinical trials, SOA should be formulated at the optimum pH of 5.40 and refrigerated at 4°C for maximum stability. The reported data can be used as a starting point for developing stable SOA formulations and estimating shelf life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Best Pharmaceuticals for Children. Food and Drug Administration and the National Institutes of Health. https://bpca.nichd.nih.gov/Pages/default.aspx. Accessed on 2/11/2017.

  2. US Food and Drug Administration. Intra-agency agreement between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the U.S. Food and Drug Administration (FDA) oral formulations platform—report 1. https://bpca.nichd.nih.gov/collaborativeefforts/initiatives/documents/formulations_platform_report1.pdf. Accessed on 2/11/2017.

  3. US Food and Drug Administration. Inter-agency agreement between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the U.S. Food and Drug Administration (FDA) final report. https://bpca.nichd.nih.gov/collaborativeefforts/initiatives/Documents/Formulations_Platform_Report2.pdf. Accessed on 2/11/2017.

  4. Better medicines for children. European Medicines Agency. www.ema.europa.eu/docs/en_GB/document_library/Other/2009/12/WC500026493.pdf. Accessed on 2/11/2017.

  5. Reflection paper: formulations of choice for the paediatric population. European Medicines Agency. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003782.pdf. Accessed on 2/11/2017.

  6. Essential medicines list for children (EMLc); palliative care. World Health Organization. http://www.who.int/selection_medicines/committees/subcommittee/2/palliative.pdf. Accessed 2/11/2017.

  7. Zajicek A, Fossler MJ, Barrett JS, Worthington JH, Ternik R, Charkoftaki G, et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS J. 2013;15(4):1071–81. doi:10.1208/s12248-013-9511-5.

    Article  Google Scholar 

  8. Sucrose octaacetate. United States Pharmacopoeia, USP-NF online <11> USP37-NF32, pp 6233–6234. Accessed on 12/02/2016.

  9. Smith DS, Helzner EC, Nuttall CE Jr, Collins M, Rofman BA, Ginsberg D, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother. 1989;33(5):646–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhao X, Xia H, Liu P, Wu A, Jiang H, Li S. Method for preparing placebo of traditional Chinese medicine preparation for treating gonarthromeningitis. Luoyang: Henan Luozheng Pharmaceutical Factory; 2012. Patent 6pp.

  11. Schiffman SS, Gatlin LA, Sattely-Miller EA, Graham BG, Heiman SA, Stagner WC, et al. The effect of sweeteners on bitter taste in young and elderly subjects. Brain Res Bull. 1994;35(3):189–204.

    Article  CAS  PubMed  Google Scholar 

  12. Schiffman SS, Gatlin LA, Frey AE, Heiman SA, Stagner WC, Cooper DC. Taste perception of bitter compounds in young and elderly persons: relation to lipophilicity of bitter compounds. Neurobio Aging. 1994;15(6):743–50.

    Article  CAS  Google Scholar 

  13. Schiffman SS, Gatlin LA, Suggs MS, Heiman SA, Stagner WC, Erickson RP. Modulators of the adenylate cyclase system can alter electrophysiological taste responses in gerbil. Pharmacol Biochem Behav. 1994;48(4):983–90.

    Article  CAS  PubMed  Google Scholar 

  14. Schiffman SS, Suggs MS, Losee ML, Gatlin LA, Stagner WC, Bell RM. Effect of lipid-derived second messengers on electrophysiological taste responses in the gerbil. Pharmacol Biochem Behav. 1995;52(1):49–58.

    Article  CAS  PubMed  Google Scholar 

  15. Code of Federal Regulations. 21 CFR 310.536. Nailbiting and thumbsucking deterrent drug products for over-the-counter human use. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=310.536. Accessed 2/11/2017.

  16. Code of Federal Regulations. 21 CFR 172.515. Synthetic flavoring substances and adjuvants. https://www.gpo.gov/fdsys/pkg/CFR-2001-title21-vol3/pdf/CFR-2001-title21-vol3-sec172-515.pdf. Accessed 2/11/2017.

  17. Winter R. A Consumer’s dictionary of food additives. New York: Three Rivers Press; 2009. p. 505–6.

    Google Scholar 

  18. Code of Federal Redulations. 21 CFR 175.300. Indirect food additives: adhesives and components of coatings. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfr/CFRSearch.cfm?fr=175.300. Accessed 6/15/2017.

  19. Code of Federal Regulations. 27 CFR 21.151. List of denaturants authorized for denatured spirits. https://www.gpo.gov/fdsys/pkg/CFR-2013-title27-vol1/pdf/CFR-2013-title27-vol1-sec21-151.pdf. Accessed 5/15/2017.

  20. Chung H, Seib PA, Finney KF, Magoffin CD. Sucrose monoesters and diesters in breadmaking. Cereal Chem. 1981;58(3):164–70.

    CAS  Google Scholar 

  21. Parmar R, Ghanta A, Haware RV, Johnson PR, Stagner WC. Statistical optimization of ELSD for molten sucrose octaacetate and comparison with UV-DAD validation parameters using tandem HPLC UV-DAD/ELSD specific stability-indicating method. J Pharm Sci. 2016;105:3603–10. doi:10.1016/j.xphs.2016.08.030.

    Article  CAS  PubMed  Google Scholar 

  22. Rathbone EB, Lee CK, Birch GG. Stability of sugar acetates in citric acid solution. Food Chem. 1980;5:1939–46.

    Article  Google Scholar 

  23. Stuve EM. Estimating and plotting logarithmic error bars. Copyright 2004–12. http://faculty.washington.edu/stuve/uwess/log_error.pdf. Accessed on 1/24/17.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William C. Stagner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaddam, S., Stagner, W.C. Sucrose Octaacetate Chemical Kinetics and Shelf Lives at Various Formulation pHs. AAPS PharmSciTech 19, 176–183 (2018). https://doi.org/10.1208/s12249-017-0829-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-017-0829-7

KEY WORDS

Navigation